NC | NC@drug | Material advantage | Specificity | References |
---|---|---|---|---|
Liposomes | Liposomal doxorubicin | Improved delivery to site of disease; decrease in systemic toxicity of free drug | Ovarian cancer; multiple myeloma | [172] |
 | Liposomal daunorubicin | Improved delivery to tumour site; lower systemic toxicity arising from side effects | Karposi’s sarcoma | [173] |
 | Genistein and plumbagin encapsulated nanoliposomes | Inhibition of cell metabolism | In vitro and in vivo prostate cancer | [174] |
 | Folate-conjugated bovine serum albumin bound paclitaxel NPs | Increased solubility, cellular uptake; targeted specificity | Prostate cancer cells | [175] |
Protein-based NPs | Alpha mangostin loaded crosslinked silk fibroin-based NPs | Physico-chemically stable, increased the drug's solubility | Colorectal and breast cancer | [176] |
 | Noscapine-loaded human serum albumin NPs | High drug-loading efficiency (85–96%) and delivery of maximum quantity of drug to the tumour site | Breast cancer cells | [177] |
 | Plasmid cDNA (pGL3) polyethyleneimine (PEI)-coated HSA NPs | Enhance endosomal escape | In vitro gene delivery application | [178] |
Micelles | Polymeric methoxy-PEG-poly(D,L-lactide) micelle formulation of paclitaxel | Improved delivery to site of disease; decrease in systemic toxicity of free drug | Breast cancer; ovarian cancer | [179] |
 | Folate-PEG/Hyd-curcumin/C18-g-polysuccinimide | pH sensitive drug release | Colon cancer | [180] |
 | PEGylated prodrug nano-micelles | Glucose-sensitive | In vitro and in vivo anticancer activity | [181] |
Polymeric Micelles | CD44v6-targeted polymeric micelles (PM) loaded with niclosmide | Increase drug safety | Efficacy against colorectal stem cells | [182] |
Self-assembly | Aptamer-tethered DNA assembly | Stronger targeting ability, higher cellular uptake | Cancer cell imaging | [183] |
 | DNA-aptamer conjugated RNA-triple helix hydrogel | Efficient cellular uptake and enhanced nuclease resistance with superior biocompatibility | Triple negative breast cancer detection and treatment | [184] |
 | Folate-modified MPEG-PCL | Improved bioavailability, low toxicity, sustained drug release | Colorectal cancer mice model | [185] |
 | Folate receptor-targeted β-cyclodextrin (β-CD) | Biosafety, bioavailability, and improve curcumin drug loading capacity | Cervical cancer, fibroblast cells | [186] |